CLINICAL, NEUROPHYSIOLOGICAL AND IMMUNOLOGICAL STUDIES OF CANCER PATIENTS WITH LESIONS OF THE PERIPHERAL NERVES
https://doi.org/10.20538/1682-0363-2013-5-39-45
Abstract
Clinical electrophysiological and immunological studies of 88 cancer patients showed that in breast cancer and small lung cancer takes place symmetric, distal, sensory-motor, axonal-demyelinating polyneuropathy. Autoimmune nature of the disease confirmed onconeural antigens detected in the serum of more than half of the study participants.
About the Authors
Ye. S. Korolyova
Siberian State Medical University, Tomsk
Russian Federation
Korolyova Yekaterina S.
Russian Federation
Korolyova Yekaterina S.
V. M. Alifirova
Siberian State Medical University, Tomsk
Russian Federation
Alifirova Valentina M.
Russian Federation
Alifirova Valentina M.
V. Ye. Goldberg
Institute of oncology SB RAMS, Tomsk
Russian Federation
Goldberg Viktor Ye.
Russian Federation
Goldberg Viktor Ye.
N. S. Novikova
Siberian State Medical University, Tomsk
Russian Federation
Novikova Natal’ya S.
Russian Federation
Novikova Natal’ya S.
I. A. Zhukova
Siberian State Medical University, Tomsk
Russian Federation
Zhukova Irina A.
Russian Federation
Zhukova Irina A.
References
1. Komantsev V.N., Zabolotnykh V.A. Methodical bases of clinical electromyograghic: A Guide for Physicians. St. Petersburg, Lan Publ., 2006. 350 p. (in Russian).
2. Koroleva Ye.S., Goldberg V.Ye., Alifirova V.M., Simolyna Ye.I., Novikova N.S. Siberian Journal of Oncology, 2012, vol. 4 (52), pp. 25–29 (in Russian).
3. Semenova A.I. Practical Oncology, 2009, vol. 3 (10), pp. 168–176 (in Russian).
4. Ansari J., Nagabhushan N., Syed R. Small cell lung cancer assotiated with anti-Hu paraneoplastic sensory neuropathy and peripheral nerve microvasculitis: case report and literature review. Clin. Oncol., 2004, vol. 16 (1), pp. 71–76.
5. Antoine J.C., Mosnier J.F., Honnorat J. Paraneoplastic demyelinating neuropathy, subacute sensory neuropathy, and anti-Hu antibodies: clinic-pathological study of an autopsy case. Muscle Nerve, 1998, vol. 21, no. 7, pp. 850–857.
6. Antoin J.C., Camdessanche J.P. Paraneoplastic peripheral neuropathy. Rev. Neurol., 2004, vol. 160 (2), pp. 188–198.
7. Dalmau J., Graus F. Paraneoplastic syndromes of the nervous system. Cancer of the nervous system. Ed. J.S. Loeffler. Oxford, Blackwell Scientific Publications, 1997. P. 674–700.
8. Dalmau J., Furneaux H.M., Cordon-Cardo C., Posner J.B. The expression of the Hu (paraneoplastic encephalomyelitis/sensory neuronopathy) antigen in human normal and tumor tissues. Am. J. Pathol., 1992, vol. 141 (8), pp. 81–86.
9. Darnell J.C., Albert M.L., Darnell R.B. Cdr2, a target antigen of naturally occurring tumor immunity, is widely expressed in gynecologic tumors. Cancer Res., 2000, vol. 60 (21), pp. 36–39.
10. Dropcho E.J. Neurologic paraneoplastic syndromes. J. Neurol. Sci., 1998, vol. 153, pp. 264–278.
11. Graus F., Elkon K.B., Cordon-Cardo C., Posner J.B. Sensory neuropathy and small cell lung cancer. antineuronal antibody that also reacts with the tumor. Amer. J. Med., 1986, vol. 80, pp. 45–52.
12. Graus F., Rowe G., Fueyo J., Darnell R.B., Dalmau J. The neuronal nuclear antigen recognized by the human anti-Ri autoantibody is expressed in central but not peripheral nervous system neurons. Neurosci. Lett., 1993, vol. 150 (2), pp. 12–14.
13. Gregg R.V., Molepo J.M., Monpetit V.J. Cisplatin neurotoxicity: the relationship between dosage, time and platinum concentration in neurologic tissues, and morphologic evidence of toxicity. J. Clin. Oncol., 1992, vol. 10, pp. 795–803.
14. Grisold J.E., Drlikec M. Paraneoplastic neuropathy. Curr. Opin. Neurol., 1999, vol. 75, pp. 617–625
15. Hausbeer F.H., Scblisky R.L., Bain S. Diagnosis, management, and evaluation of chemotherapy-induced peripheral neuropathy. Semin. Oncol., 2006, vol. 33 (1), pp. 15–49.
16. Hausbeer F.H. Chemotherapy-induced peripheral neuropathy, Chapter 24. In Perry M.C. ed. The chemotherapy source book, 4 th ed. Philadelphia, Lippincott Williams&Wilkins, 2008. Pp. 234–245.
17. Honnorat J., Antoine J.C. Paraneoplastic neurological syndromes. Orphanet J. Rare Dis., 2007, vol. 2, pp. 22.
18. Kawasoe T., Yamamoto Y., Okumura Y., Iwase H. A case report of. paraneoplastic neurological syndrome associated with occult breast cancer. Breast Cancer, 2006, vol. 13 (2), pp. 202–204.
19. Storstein A., Monstad S.E., Haugen M. et al.Onconeural antibodies: Improved detection and cinical correlations. J. Neuroimmunology, 2011, vol. 232, pp. 166–170.
20. Ritzinhtaler T., Verret J.M., Honnorat. J. Paraneoplastic chorea and behavioral disorders in patients with anti-CV2 /CRMP5 antibodies and two different tumors. Rev. Neurol. (Paris), 2010, vol. 166 (1), pp. 90–95.
21. Rojas-Marcos J., Rousseau A., Keime-Guibert F. spectrum of paraneoplastic neurologic disorders in women with breast and gynecologic cancer. Medicine, 2003, vol. 82 (3), pp. 216–223.
22. Rosenfeld M., Posner J.B. Paraneoplastic syndromes and progressin motor dysfunctions. Semin. Neurol., 1993, vol. 13, pp. 291–298.
23. Rowinsky E.K., Eisenbauer E.A., Cbaudbry V.Clinical toxicities encountered with paclitaxel (Taxol). Semin. Oncol., 1993, vol. 20 (3), pp. 1–15.
24. Saijo A., Doi H., Urata T. Improvement of neurologic symptoms after chemoradiotherapy in a patient with small cell lung cancer associated with paraneoplastic neurologic syndrome. Nihon Kokjuki Gakkai Zasshi, 2009, vol. 47 (1), pp. 37–41.
25. Tashima M., Kamakari K., Ishikawa H. A case of paraneoplastic syndrome improved following chemoradiotherapy for lung cancer. Nihon Kokjuki Gakkai Zasshi, 2003, vol. 41 (3), pp. 219–222.
Review
For citations:
Korolyova Ye.S., Alifirova V.M., Goldberg V.Ye., Novikova N.S., Zhukova I.A. CLINICAL, NEUROPHYSIOLOGICAL AND IMMUNOLOGICAL STUDIES OF CANCER PATIENTS WITH LESIONS OF THE PERIPHERAL NERVES. Bulletin of Siberian Medicine. 2013;12(5):39-45. (In Russ.) https://doi.org/10.20538/1682-0363-2013-5-39-45
Views:
744
Email this article 